Salmon Peptide Supplement for Metabolic Syndrome (SPF1 Trial)

N/A

Waitlist Available

Research Sponsored by Laval University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Meet at least one of the following criteria: Plasma TG > 1.35 mmol/L, Fasting glycemia ≥ 5.6 mmol/L and ≤ 6.9 mmol/L, HbA1c ≥ 5.7% and ≤ 6.4%, Insulin concentration > 42 pmol/L

Be older than 18 years old

Must not have

Suffering from any metabolic disorder requiring pharmacological treatment

>5% weight loss over the last 3 months

Timeline

Screening 3 weeks

Treatment Varies

Follow Up change between the beginning and th end of the intervention (6 weeks)

Awards & highlights

No Placebo-Only Group

Summary

This trial will test the safety and effects of two doses of salmon peptide fraction on metabolic syndrome risk factors in overweight-obese men and women.

Who is the study for?

This trial is for overweight-obese men and women with a waist size of at least 94 cm for men or 80 cm for women. They must have certain metabolic syndrome risk factors like high triglycerides, blood sugar, HbA1c, or insulin levels but can't be on any related medications. No recent weight loss, surgery, or use of supplements affecting metabolism is allowed.

What is being tested?

The study tests the safety and effects on cardiometabolic health of two doses (7.5g and 15g) of salmon peptide fraction in participants with metabolic syndrome. It uses advanced biological analysis to understand how these supplements might work.

What are the potential side effects?

While specific side effects are not listed here, potential risks may include allergic reactions due to fish/seafood ingredients in the supplement or gastrointestinal discomfort as commonly seen with dietary supplements.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My blood tests show high triglycerides, blood sugar, HbA1c, or insulin levels.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I am on medication for a metabolic disorder.

Select...

I have lost more than 5% of my weight in the last 3 months.

Select...

I am taking medication that affects my blood sugar or cholesterol levels.

Select...

I have not had major surgery in the last 3 months.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ change between the beginning and th end of the intervention (6 weeks)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~change between the beginning and th end of the intervention (6 weeks)

This trial's timeline: 3 weeks for screening, Varies for treatment, and change between the beginning and th end of the intervention (6 weeks) for reporting.